Age, Biography and Wiki
Máté Hidvégi was born on 9 November, 1955 in Budapest, Hungary, is a Mate Hidvegi is biochemist and co-inventor of Avemar and Oncomar. Discover Máté Hidvégi's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 68 years old?
| Popular As |
N/A |
| Occupation |
N/A |
| Age |
68 years old |
| Zodiac Sign |
Scorpio |
| Born |
9 November 1955 |
| Birthday |
9 November |
| Birthplace |
Budapest, Hungary |
| Nationality |
Hungary
|
We recommend you to check the complete list of Famous People born on 9 November.
He is a member of famous with the age 68 years old group.
Máté Hidvégi Height, Weight & Measurements
At 68 years old, Máté Hidvégi height not available right now. We will update Máté Hidvégi's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
Máté Hidvégi Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is Máté Hidvégi worth at the age of 68 years old? Máté Hidvégi’s income source is mostly from being a successful . He is from Hungary. We have estimated Máté Hidvégi's net worth, money, salary, income, and assets.
| Net Worth in 2024 |
$1 Million - $5 Million |
| Salary in 2024 |
Under Review |
| Net Worth in 2023 |
Pending |
| Salary in 2023 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
|
Máté Hidvégi Social Network
| Instagram |
|
| Linkedin |
|
| Twitter |
|
| Facebook |
|
| Wikipedia |
|
| Imdb |
|
Timeline
Mate Hidvegi (born 9 November 1955 in Budapest, Hungary) is a Hungarian biochemist and co-inventor of Avemar and Oncomar, fermented wheat germ extract based nutraceuticals.
Hidvegi was born in Budapest, Hungary, on 9 November 1955.
He is the son of György Hidvégi-Hoffmann and Katalin Dávid.
He received his Bachelor of Science in 1978 and Master of Science in 1980 from Technology University Budapest.
He also received his Doctor of Philosophy from Technology University Budapest in 1983.Then he taught at what is now Budapest University of Technology and Economics from 1984-1987 as assistant professor and since 1992 as professor.
After finishing university, he worked in the cereal industry and was co-developer of a patented feed advisory system based on near infrared ingredient data.
Hidvegi was the pioneer in the development of technologies of mass-production and therapeutic use of instantized herbal extracts in Hungary.
Between 1988-1990 Hidvegi was Post-Doctoral Fellow at the Grain Research Laboratory of the Canadian Grain Commission, Winnipeg, Canada.
Hidvegi invented and hold the patent for the manufacturing process of an alfalfa-based extract (Esterin), which has been claimed to lower serum cholesterol levels (U.S patent 5,277,910 January 11, 1994).
Hidvegi is the co-inventor of a patented fermented wheat germ extract-based nutraceutical known as Avemar.
In the U.S., Avemar is classified as a dietary supplement and marketed under the trade name Ave (American BioSciences, Inc.; Blauvelt, NY).
In Hungary Avemar as a dietary food for cancer patients.
In 1996 Hidvegi was co-founder of Biromedicina (joint stock company), what is now called The First Hungarian Corporation for Cancer Research and Oncology.
The company’s mission was to market Hidvegi's product Avemar, a fermented wheat germ extract-based nutraceutical.
Hidvegi holds a PhD and a Dr. Habil in chemistry, and an honorary professorship at the Jewish University, Budapest.
Hidvegi's first publications were about the theories of the origins of life, and the elaboration of a plausible mechanism for the biogenesis and evolution of biomembranes.
He worked out the metabolic map as well as the reaction kinetics of a theoretical first living cell.
In 2009 Hidvegi marketed a new dietary food for special medical purposes for cancer patients based on the Avemar, which was sold as Oncomar and (in the U.S.) AvéUltra.
